AMA Moves Urology Category III CPT Codes to October 1, 2026

Editorial Transparency
Created by: Billing Service Quotes Editorial Team (Urology Bill Co is powered by Billing Service Quotes).
Technical Review: Tim Daniels, Director of Strategic Accounts, Billing Service Quotes.
Billing Service Quotes is a matching platform for providers searching for vetted medical billing companies. Finding a match is 100% for providers.

QUICK ANSWER

  • What changed with urology Category III CPT codes? As of August 2026, the AMA has moved a block of Category III CPT codes to an October 1, 2026 effective date, three months earlier than the January 1, 2027 date it first published. Eight of those codes describe urology services, including bladder lesion cryotherapy, post-lithotripsy stone fragment propulsion, and algorithmic analysis of bladder and prostate cancer tissue.
  • Eight urology codes sit in the block: 1054T, 1063T, 1064T, 1065T through 1068T, and 1107T all become reportable on October 1, 2026.
  • The release schedule changed permanently: Category III updates move from twice a year in January and July to three times a year in April, July, and October.
  • No RVUs are attached: Category III codes carry no relative value units, so every payment decision belongs to the payer rather than the Medicare fee schedule.

What the AMA Changed on August 7

On August 7, 2026, the AMA updated its Category III code documents to reflect an action taken by the CPT Editorial Panel at its August 2026 meeting. The change did two things at once. It revised the introductory guidelines so Category III releases now publish three times a year instead of twice, and it pulled forward the effective date for every code released in July 2026.

Those July codes are 0894T through 0896T and the full 1054T through 1111T range. All of them were originally scheduled to become reportable on January 1, 2027, following the standard six-month implementation window that began July 1, 2026. That window has been cut roughly in half. The codes are now live on October 1, 2026.

The change is documented directly in the AMA Category III code files. Both the Category III long descriptor document and the corresponding short descriptor file carry an August 7, 2026 revision stamp and list the new October 1 date beside the original January 1, 2027 date for each affected code.

For urology, this is not a footnote. Category III is where new urologic technology lives before it earns a Category I code. Aquablation spent years as 0421T before converting. The absorbable urologic scaffold add-on code 1042T went live in July 2026. Practices that adopt new devices early tend to carry more Category III volume than practices in most other specialties, which means a compressed implementation window lands harder here.

The operational problem is straightforward. A January 1 effective date lands inside the annual code update cycle that every practice management system already runs. An October 1 date does not. It falls in the middle of the fourth quarter, when most urology groups are working through year-end scheduling, benefit verification for the coming plan year, and open enrollment questions from patients. There is no standing process that catches it.

Which Urology Codes Move to October 1, 2026?

Eight codes in the accelerated block describe urology services. They cover stone management, bladder lesion treatment, and digital pathology for bladder and prostate cancer. The table below pairs each code with its original and revised effective date.

CodeWhat It DescribesOriginal Effective DateNew Effective Date
1054TFocused non-shock wave ultrasonic propulsion of residual stone fragments 5 mm or smaller after lithotripsy, unilateral, including ultrasound guidanceJanuary 1, 2027October 1, 2026
1063TBladder cancer augmentative algorithmic analysis of digitized slides, reported as prognostic of recurrence and progression in high-grade non-muscle-invasive diseaseJanuary 1, 2027October 1, 2026
1064TSame bladder cancer analysis, reported as predictive of response to Bacillus Calmette-Guerin therapyJanuary 1, 2027October 1, 2026
1065T to 1068TCystourethroscopy with CO2 cryotherapy spray in a gaseous bladder environment with pressure monitoring, tiered by total lesion diameterJanuary 1, 2027October 1, 2026
1107TProstate cancer augmentative algorithmic analysis of digitized slides, reported as 10-year risk of distant metastasis and prostate cancer specific mortalityJanuary 1, 2027October 1, 2026

The cystourethroscopy family is the one most practices will notice first. Codes 1065T through 1068T report CO2 cryotherapy spray delivered in a gaseous bladder environment with pressure monitoring, and they are tiered by the total diameter of the lesions treated. Minor covers total lesion diameters under 0.5 cm, small covers 0.5 cm up to 2.0 cm, medium covers 2.0 cm up to 5.0 cm, and large covers 5.0 cm and above.

The AMA attached an explicit cross-reference to this family: when bladder lesions are treated in a nongaseous environment with fulguration, the correct codes remain 52224, 52234, 52235, and 52240. That distinction matters because the cystoscopy family already generates a high denial volume, and our breakdown of diagnostic cystoscopy billing and NCCI bundling covers how easily a coder can land on the wrong member of that code set.

Code 1054T carries its own restriction. It reports focused non-shock wave ultrasonic propulsion of residual stone fragments 5 mm or smaller after lithotripsy, unilateral, and it already includes the ultrasound guidance. The AMA instructs that 1054T not be reported alongside 76700, 76705, 76770, 76775, 76856, 76857, or 76998 when those are performed together on the same side. Billing the guidance separately is the obvious error, and it is now an error that can happen three months earlier than anyone planned for.

Why the AMA Compressed the Release Schedule

The stated purpose of Category III codes is data collection. They exist so that CMS, commercial payers, health services researchers, and policy analysts can track how often an emerging service is actually performed. A code that sits unpublished for six months collects nothing, and the AMA has been steadily shortening that lag as technology cycles have compressed.

Moving to an April, July, and October cadence gives the code set three entry points a year instead of two. It also aligns Category III releases more closely with the quarterly rhythm most payers already run for coverage policy updates and edit file refreshes. The practical effect is that a device or service cleared in the spring can start generating utilization data in the same calendar year rather than waiting until the next one.

There is a second effect the AMA does not spell out. Faster publication means faster accumulation of the utilization evidence a Category III code needs to convert to Category I. For urology, where several BPH and bladder cancer technologies are working toward permanent codes, a shorter runway to data collection is a shorter runway to real fee schedule values. The tradeoff is that practices get less time to prepare, and the burden of that tradeoff falls on the billing side.

It is worth being precise about what did and did not change. The AMA did not add codes, delete codes, or revise any urology descriptor in this action. The clinical content of 1054T, 1063T, 1064T, 1065T through 1068T, and 1107T is identical to what was published on July 1, 2026. Only the date on which those codes become reportable moved. A practice that already loaded the July release into its system has the descriptors right and the activation date wrong, which is a quieter failure than a missing code and easier to miss on a spot check.

What Does a Category III CPT Code Pay in Urology?

Across the billing companies we vet, this is the question that generates the most confusion when a practice adopts new technology. Category III codes are not assigned relative value units and are not referred to the AMA Specialty Society Relative Value Scale Update Committee for valuation. Payment is set entirely by payer policy, not by the Medicare Physician Fee Schedule.

In practice, that means three outcomes are possible for any given claim. The payer covers the service under a written policy and pays a negotiated or contractor-priced amount. The payer treats the service as investigational and denies it outright. Or the Medicare Administrative Contractor prices it case by case, which produces inconsistent payment across jurisdictions for identical work.

Coverage checks therefore have to happen before the procedure, not after the denial. For urology practices in the six pilot states, this also stacks on top of the Medicare WISeR model prior authorization requirements, which added a pre-service step to traditional Medicare for the first time at scale. A Category III service with no coverage policy and a prior authorization requirement on the adjacent procedure is a claim that will not pay without groundwork.

One more detail affects the pathology codes specifically. For 1107T, the AMA instructs that the code not be reported with 88305, 88307, 88309, or 88363 for hematoxylin and eosin staining when that staining was performed solely to support the algorithmic analysis. The same instruction applies to the bladder codes 1063T and 1064T. Practices sending tissue to a digital pathology vendor should confirm who is reporting what before the first claim goes out.

What to Do Before October 1

The window between the announcement and the effective date is short. These seven steps cover the operational work that has to happen inside a urology practice before the codes go live.

  • Pull the current AMA Category III files and confirm which of the eight urology codes your practice will actually perform.
  • Load the applicable codes into the practice management system and the EMR charge capture template with an October 1, 2026 activation date, not a January 1, 2027 date.
  • Contact each major commercial payer in writing to request the current coverage position on the specific codes you plan to report.
  • Check your Medicare Administrative Contractor bulletin page for any local coverage determination or contractor pricing guidance tied to the new codes.
  • Update the operative note template so it captures the details each code requires, including total lesion diameter for 1065T through 1068T and laterality for 1054T.
  • Brief the coding team on the bundling instructions, particularly the imaging exclusions on 1054T and the staining exclusions on 1063T, 1064T, and 1107T.
  • Build a patient financial responsibility and advance beneficiary notice workflow for any service the payer has not agreed in writing to cover.

Providers often come to us after the first denial wave rather than before it, and by then the practice has already performed a run of procedures against a code the payer never agreed to pay. The cost of that sequence is rarely the denial itself. It is the write-off on services already delivered.

New Category III codes go live October 1, 2026, and payment on every one of them depends on payer policy rather than the fee schedule. Get matched with vetted medical billing companies that already handle urology coverage verification and Category III claims. Comparing quotes is 100% free for providers.

What Happens If You Bill a Category III Code Too Early?

A Category III code submitted before its published effective date is rejected as an invalid code for the date of service. The claim does not pend or price at zero. It fails front-end edits at the clearinghouse or the payer, and the practice has to correct the date of service or the code and resubmit, which restarts the timely filing clock.

The most common issue we see providers run into is the mirror image of this problem. A practice reads an early release announcement, assumes the code is immediately usable, and reports it weeks before the implementation date. The AMA is explicit that early publication to its website does not make a code reportable before the stated implementation date. Publication and effectiveness are two separate events.

The reverse error is just as expensive. When a code becomes valid and the superbill still points at an unlisted code or a superseded one, claims go out wrong until someone notices. That is exactly the pattern that followed the 2026 prostate biopsy code overhaul, where practices that left the deleted code on the template saw every biopsy claim deny until the template was fixed. A compressed 90-day window makes that failure mode more likely, not less.

There is also a documentation risk that does not show up until an audit. Because Category III codes have no assigned values, some practices treat them as low stakes and let the operative note stay thin. Payers reviewing a contractor-priced or negotiated Category III claim look at the note first, and a note that omits lesion diameter or laterality will not support the code that was billed.

In-House Code Maintenance vs. a Billing Partner

Most urology practices maintain their code files on an annual cycle. Someone loads the January CPT update, checks the fee schedule, and closes the task until the following winter. That model worked when the AMA published Category I annually and Category III twice a year. It does not survive a triannual release calendar layered on top of quarterly NCCI and HCPCS updates.

The practices that handle this well have moved to a standing quarterly review. They check the AMA release files in April, July, and October, reconcile them against the practice management system, and confirm payer coverage on anything new before it reaches a claim. That is a few hours of work per quarter, and it is the difference between catching a change and discovering it through a denial report.

In our experience matching providers with billing partners, the practices that struggle most are single-specialty groups with one or two administrative staff carrying billing alongside scheduling and front desk duties. Code maintenance is the first task that slips when the day gets busy, and it is the one with the longest lag between the mistake and the visible consequence. A billing company that monitors code set releases as part of its standard service absorbs that work entirely.

There is a middle path worth naming. A practice that wants to keep billing in house can still assign the code release calendar to a named person and put the three AMA publication dates on a recurring calendar with a two-week lead time. The failure is almost never a lack of skill. It is a lack of ownership, where everyone assumes the code file updates itself because it always seemed to before.

The question worth asking is not whether your current setup can handle one schedule change. It is whether it can handle three code releases a year, every year, without anyone having to remember.

CPT codes and descriptors are maintained by the American Medical Association and are provided here for reference. Category III codes carry no assigned relative value units, so coverage and payment are set by each payer, and effective dates are set by the AMA. Verify against the current AMA Category III files, your MAC guidance, and payer policies before billing.

Frequently Asked Questions

When do the new urology Category III CPT codes take effect?

October 1, 2026. The AMA originally published these codes with a January 1, 2027 effective date, then moved that date forward following a CPT Editorial Panel action at its August 2026 meeting. The revised Category III code documents on the AMA website carry an August 7, 2026 update stamp.

Which urology codes are affected by the schedule change?

Eight codes: 1054T for post-lithotripsy stone fragment propulsion, 1063T and 1064T for bladder cancer algorithmic analysis, 1065T through 1068T for cystourethroscopy with CO2 cryotherapy spray, and 1107T for prostate cancer algorithmic analysis. All eight become reportable October 1, 2026.

Do Category III CPT codes have Medicare reimbursement rates?

No. Category III codes are not assigned relative value units and are not valued through the Medicare Physician Fee Schedule. Payment depends entirely on payer policy. A Medicare Administrative Contractor may price the service case by case, and commercial payers may cover, deny, or negotiate it individually.

How often does the AMA release Category III codes now?

Three times a year, in April, July, and October. The previous schedule published updates twice a year in January and July. The AMA revised its Category III introductory guidelines in August 2026 to reflect the new triannual cadence, which applies going forward, not just to the current release.

Can I bill 1065T through 1068T with fulguration codes?

No. The AMA cross-reference is explicit. Codes 1065T through 1068T report CO2 cryotherapy spray in a gaseous bladder environment. When bladder lesions are treated in a nongaseous environment with fulguration, report 52224, 52234, 52235, or 52240 instead. The two approaches are alternatives, not companions.

Is ultrasound guidance billable separately with 1054T?

No. Ultrasound guidance is included in 1054T. The AMA instructs that 1054T not be reported with 76700, 76705, 76770, 76775, 76856, 76857, or 76998 when those services are performed together on the same side. Reporting guidance separately will trigger an unbundling denial.

What happens to these codes after October 1?

They remain Category III codes and appear in the CPT 2027 code set. A Category III code is generally archived five years after initial publication unless it converts to a Category I code first. Conversion depends on accumulated utilization data, which is the reason the earlier effective date matters.

Next Steps

  • Reviewing cystoscopy coding ahead of the new bladder codes? Start with our diagnostic cystoscopy guide for the bundling rules that already govern that code family.
  • Rebuilding superbill templates? The 2026 prostate biopsy code changes show what a missed template update costs.
  • Practicing in a WISeR pilot state? Confirm your prior authorization workflow before layering new Category III services on top of it.
  • Want the code maintenance handled for you? Get matched with urology billing companies that track AMA release files every quarter and verify coverage before the claim goes out.
  • Adopting a new device this quarter? Request the payer coverage position in writing before the first case is scheduled, not after the first claim is denied.
  • Not sure which of the eight codes apply to you? Start with the procedures your practice already performs, then check the AMA descriptors against your operative note templates.

Three Category III releases a year is a permanent change, and the next one lands in April. Billing Service Quotes matches urology practices with vetted medical billing companies that monitor code set releases, verify payer coverage before the procedure, and keep your templates current. Over 2,000 providers matched across all 50 states, with rates starting as low as 2.95%. Finding a match is 100% free for providers.

Tags :
Share it :

Where should we send your quote(s)?

We'll send it directly to your inbox

How many providers does your practice have?

We'll find a billing company that can support your needs

Where is your practice located?

We'll find a billing company that serves providers in your area

loading

Get Matched In 30 Minutes

Get a FREE Quote

Tell us about your practice and we'll connect you with trusted billing companies.

100% Free to providers — No hidden fees at any stage

Tim Daniels
Online now
Tim Daniels

How can I help?

Send me your number and I'll personally call you in less than 24 hours to discuss any questions you may have about our urology billing partners

Mon–Fri, 9:00am–5:30pm Or email instead →
Got it — talk soon.
I'll call you within one business hour. Check your phone for an unknown number.